project year

2028

A new targeted therapy for resistant HER2+ breast cancers

A targeted therapy to enhance treatment efficacy and neuroprotection in glioblastoma

Advancing Liquid Biopsy Testing: Harnessing Epigenetics for Early Detection of Residual and Recurrent Breast Cancer

Advancing Telomerase Inhibitors as potential cancer therapeutics

Doubling access while halving toxicity with adaptive lung cancer radiotherapy

Dual targeting of oncogenic cofactors MYC and histone deacetylase in high-risk childhood brain tumours

Improved MRI-guided radiotherapy for pancreatic cancer enabled by robust artificial intelligence

Nanobody-mediated modulation of unconventional T cells for cancer immunotherapy

Precision targeting of regulatory T cells for solid cancer immunotherapy

Priming with Belinostat to chemo-sensitise high-risk neuroblastoma

Selective targeting of CDK4 to improve breast and prostate cancer treatment

Uncovering the biology of Chronic Myelomonocytic Leukaemia to identify prognostic and treatment opportunities

Unveiling the potential of copper chelation as a cutting-edge epigenetic therapy for Diffuse Midline Glioma

Help us to put an end to cancer